Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers
- PMID: 6977610
- PMCID: PMC2186609
- DOI: 10.1084/jem.155.3.872
Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers
Abstract
Evidence is presented that T cells that produce lethal graft-vs.-host disease (GVHD) to minor histocompatibility antigens (minor HA) comprise discrete subgroups of H-2K- and H-2D-restricted T cells; double negative selection of T cells in irradiated H-2 recombinant mice was used to separate these two subgroups. No evidence could be found that I-restricted T cells contributed to GVHD, either as effector cells or helper cells. The (unprimed) precursor cells for GVHD expressed the Thy-1+, Lyt-1+/-2, Ia- phenotype. Studies in which H-2-semiallogeneic bone marrow chimeras were used as hosts for negative selection suggested that presentation of minor HA to T cells during the induction phase is controlled by marrow-derived cells; indirect evidence was obtained that these latter cells can "process" minor HA presented on H-2 different cells and thereby render the antigens immunogenic. Studies in which minor HA-different, H-2-compatible chimeras were re-irradiated and then injected with donor-vs.-host T cells suggested that the effector phase of lethal GVHD involves contact of antigen on non-marrow-derived cells.
Similar articles
-
Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex.Immunol Rev. 1983;71:5-29. doi: 10.1111/j.1600-065x.1983.tb01066.x. Immunol Rev. 1983. PMID: 6221991 Review.
-
Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex.J Exp Med. 1980 May 1;151(5):1114-24. doi: 10.1084/jem.151.5.1114. J Exp Med. 1980. PMID: 6966318 Free PMC article.
-
Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.J Immunol. 1985 Nov;135(5):3004-10. J Immunol. 1985. PMID: 3876371
-
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.J Exp Med. 1988 Feb 1;167(2):556-69. doi: 10.1084/jem.167.2.556. J Exp Med. 1988. PMID: 2964497 Free PMC article.
-
Lethal graft-versus-host disease across minor histocompatibility barriers in mice.Clin Haematol. 1983 Oct;12(3):681-93. doi: 10.1016/s0308-2261(83)80005-8. Clin Haematol. 1983. PMID: 6416727 Review. No abstract available.
Cited by
-
MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.Am J Hematol. 2015 Nov;90(11):998-1007. doi: 10.1002/ajh.24136. Epub 2015 Oct 8. Am J Hematol. 2015. PMID: 26223969 Free PMC article.
-
Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.J Exp Med. 1987 Jun 1;165(6):1552-64. doi: 10.1084/jem.165.6.1552. J Exp Med. 1987. PMID: 3108446 Free PMC article.
-
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.Blood. 2007 Jul 1;110(1):9-17. doi: 10.1182/blood-2006-12-022038. Epub 2007 Feb 27. Blood. 2007. PMID: 17327406 Free PMC article.
-
Graft-versus-host disease.Lancet. 2009 May 2;373(9674):1550-61. doi: 10.1016/S0140-6736(09)60237-3. Epub 2009 Mar 11. Lancet. 2009. PMID: 19282026 Free PMC article. Review.
-
Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.J Exp Med. 1985 Dec 1;162(6):2068-88. doi: 10.1084/jem.162.6.2068. J Exp Med. 1985. PMID: 2933483 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous